Anosmia Market
- 2026 年市場規模
- USD 11.4 Bn
- 2033 年預估規模
- USD 18.7 Bn
- 年複合成長率 CAGR
- 8.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Anosmia Market,By Type (Idiopathic Anosmia and Congenital Anosmia), By Treatment (Therapies (Nasal Endoscopy and Imaging) and Medications (Decongestants, Antihistamines, and Steroid Nasal Sprays)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Anosmia, the clinical term for the inability to smell. This disorder impair the ability to sense odors in the environment, as well as hinder the quality of life related to social interactions, eating, and feelings of well-being. It is a severe disability, affected genetically or accidentally, resulting in total/partial absence of olfactory guidance.
Market Dynamics
Rising anosmia cases is the major factor that is expected to drive growth of the global anosmia market during the forecast period. For instance, according to an article published by the National Institute on Deafness and Other Communication Disorders in February 2019, around 3% of U.S. populace have anosmia i.e.no sense of smell.
Market players are focusing on research and development activities for offering novel products for the treatment anosmia, which is expected to drive the market growth over the forecast period. For instance, in July 2020, Zydus Cadila received the U.S. Food & Drug Administration (U.S. FDA) approval for its supplemental abbreviated new drug application (SANDA) for Doxycycline Injection USP, 100 mg/vial, which seems to improve respiratory symptoms and anosmia
Key features of the study
• This report provides in-depth analysis of the global anosmia market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global anosmia market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Mylan N.V., Pfizer Inc., Atom Pharma, RANBAXY LABORATORIES LIMITED, Alde Medi Impex, GlaxoSmithkline plc, Sandoz (Novasrtis AG), Inke S.A., Taj Pharmaceuticals Limited, and Sanofi, amongst others.
• Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global anosmia market report caters to various stakeholders in this industry including investors, suppliers, anosmia manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global anosmia market.
Anosmia Market Segmentation
• By Type
o Idiopathic Anosmia
o Congenital Anosmia
• By Treatment (Revenue, USD Bn, 2021-2033)
o Therapies
o Nasal Endoscopy
o Imaging
o Medications
o Decongestants
o Antihistamines
o Steroid Nasal Sprays
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Mylan N.V.
o Pfizer Inc.
o Atom Pharma
o RANBAXY LABORATORIES LIMITED
o Alde Medi Impex
o GlaxoSmithkline plc
o Sandoz (Novasrtis AG)
o Inke S.A.
o Taj Pharmaceuticals Limited
o Sanofi
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Type
Market Snippet, By Treatment
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Key Highlights
o Product Pipeline
o Regulatory Scenario
o Product launch/Approvals
o PEST Analysis
o Merger and Acquisition Scenario
o Market Share Analysis
4. Global Anosmia Market, By Type, 2021 - 2033 (USD Bn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Idiopathic Anosmia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Congenital Anosmia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Anosmia Market, By Treatment, 2021 - 2033 (USD Bn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Therapies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Nasal Endoscopy
o Imaging
Medications
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Decongestants
o Antihistamines
o Steroid Nasal Sprays
6. Global Anosmia Market, By Region, 2021 - 2033 (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022-2033
Regional Trends
o North America
Market Size and Forecast, By Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o South Africa
o Central Africa
o North Africa
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Mylan N.V.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Atom Pharma
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
RANBAXY LABORATORIES LIMITED
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Alde Medi Impex
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
GlaxoSmithkline plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Sandoz (Novasrtis AG)
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Inke S.A.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Taj Pharmaceuticals Limited
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Sanofi
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們